Literature DB >> 9817889

Comparison of two measures of human immunodeficiency virus (HIV) type 1 load in HIV risk groups.

C M Lyles1, D Vlahov, H Farzadegan, J Astemborski, J B Margolick, B A Masters, J Schroeder, T C Quinn.   

Abstract

Levels of viral burden were compared across risk group and gender populations among 485 human immunodeficiency virus type 1 (HIV-1)-infected participants consisting of 190 male injection drug users (IDUs), 92 female IDUs, and 203 homosexual men. Viral burden was quantified by a microculture technique to determine cell-associated infectious units per 10(6) peripheral blood mononuclear cells (IUPM) and by reverse transcriptase PCR (Amplicor) to determine plasma HIV RNA levels. Adjusting for CD4(+) cell count, females had a lower infectious HIV load than all males combined (0. 33 log10 lower; P = 0.004), and homosexual men had a 0.29 log10 higher infectious viral load than all IDUs combined (P = 0.001). For HIV RNA levels, females had lower levels than males (0.19 log10 lower; P = 0.04), but no differences were observed by risk group. After controlling for percent CD4(+) cells, no differences were found by risk group for either assay, but females still had a 0.25 log10 lower infectious viral load than males (P = 0.04) and a viral RNA load similar to that of males (P = 0.25). The correlation between infectious viral load and HIV RNA load was 0.58 overall, which did not differ by gender or risk group. Our data suggest that differences in viral load may exist by gender and that any differences observed by risk group are driven predominantly by gender or percent CD4(+) cell differences. These data also confirm a moderate correlation between cell-associated infectious viral load and plasma HIV RNA load, which appears to be similar by gender and across risk groups.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9817889      PMCID: PMC105256     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Comparison of lymphocyte immunophenotypes obtained simultaneously from two different data acquisition and analysis systems on the same flow cytometer.

Authors:  J B Margolick; E R Scott; K R Chadwick; H M Shapiro; A D Hetzel; S J Smith; R F Vogt
Journal:  Cytometry       Date:  1992

2.  Influence of gender, age, and transmission category on the progression from HIV seroconversion to AIDS.

Authors:  P Pezzotti; G Rezza; A Lazzarin; G Angarano; A Sinicco; F Aiuti; R Zerboni; B Salassa; S Gafà; R Pristerà
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992

3.  The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants.

Authors:  D Vlahov; J C Anthony; A Munoz; J Margolick; K E Nelson; D D Celentano; L Solomon; B F Polk
Journal:  NIDA Res Monogr       Date:  1991

4.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

Review 5.  Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics.

Authors:  J Lew; P Reichelderfer; M Fowler; J Bremer; R Carrol; S Cassol; D Chernoff; R Coombs; M Cronin; R Dickover; S Fiscus; S Herman; B Jackson; J Kornegay; A Kovacs; K McIntosh; W Meyer; N Michael; L Mofenson; J Moye; T Quinn; M Robb; M Vahey; B Weiser; T Yeghiazarian
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

6.  Dilution assay statistics.

Authors:  L E Myers; L J McQuay; F B Hollinger
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

7.  Human immunodeficiency virus type 1 quantitative cell microculture as a measure of antiviral efficacy in a multicenter clinical trial.

Authors:  S A Fiscus; V DeGruttola; P Gupta; D A Katzenstein; W A Meyer; M L LoFaro; M Katzman; M V Ragni; P S Reichelderfer; R W Coombs
Journal:  J Infect Dis       Date:  1995-02       Impact factor: 5.226

8.  Effect of sex, age and transmission category on the progression to AIDS and survival of zidovudine-treated symptomatic patients.

Authors:  S Vella; M Giuliano; M Floridia; A Chiesi; C Tomino; A Seeber; S Barcherini; R Bucciardini; S Mariotti
Journal:  AIDS       Date:  1995-01       Impact factor: 4.177

9.  The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.

Authors:  R A Kaslow; D G Ostrow; R Detels; J P Phair; B F Polk; C R Rinaldo
Journal:  Am J Epidemiol       Date:  1987-08       Impact factor: 4.897

10.  Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.

Authors:  W A O'Brien; P M Hartigan; D Martin; J Esinhart; A Hill; S Benoit; M Rubin; M S Simberkoff; J D Hamilton
Journal:  N Engl J Med       Date:  1996-02-15       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.